Healthcare
NASDAQ companies operating within the Healthcare sector, ranked by market capitalization.
| AMGN | NASDAQ | Amgen Inc. | $377.35 | -1.34% | 2.3M | $203.66B |
| GILD | NASDAQ | Gilead Sciences, Inc. | $143.72 | -0.75% | 4.2M | $178.44B |
| VRTX | NASDAQ | Vertex Pharmaceuticals Incorporated | $515.44 | +0.17% | 831K | $130.82B |
| ISRG | NASDAQ | Intuitive Surgical, Inc. | $369.15 | +2.41% | 3.3M | $130.41B |
| SNY | NASDAQ | Sanofi | $42.77 | +0.12% | 2.4M | $102.7B |
| REGN | NASDAQ | Regeneron Pharmaceuticals, Inc. | $781.49 | -1.48% | 444K | $80.51B |
| ARGX | NASDAQ | argenx SE | $984.39 | +0.04% | 182K | $61.22B |
| MRNA | NASDAQ | Moderna, Inc. | $143.97 | +5.38% | 15.4M | $57.13B |
| NTRA | NASDAQ | Natera, Inc. | $328.93 | +0.86% | 798K | $47.11B |
| RVMDW | NASDAQ | Revolution Medicines, Inc. Warrant | $11.25 | +1.72% | 15K | $44.16B |
| RVMD | NASDAQ | Revolution Medicines, Inc. | $203.77 | +0.21% | 1.4M | $43.32B |
| IDXX | NASDAQ | IDEXX Laboratories, Inc. | $504.70 | -0.36% | 402K | $39.81B |
| ONC | NASDAQ | BeOne Medicines AG | $346.51 | +1.38% | 305K | $37.03B |
| ALNY | NASDAQ | Alnylam Pharmaceuticals, Inc. | $248.68 | +0.47% | 1.2M | $33.28B |
| BIIB | NASDAQ | Biogen Inc. | $217.15 | +0.80% | 1.1M | $32.08B |
| DXCM | NASDAQ | DexCom, Inc. | $83.03 | -1.75% | 2.5M | $31.33B |
| ILMN | NASDAQ | Illumina, Inc. | $206.45 | +2.57% | 2.4M | $31.24B |
| ROIV | NASDAQ | Roivant Sciences Ltd. | $40.82 | -0.29% | 6M | $29.49B |
| GEHC | NASDAQ | GE HealthCare Technologies Inc. | $63.93 | -0.48% | 3.2M | $28.88B |
| INSM | NASDAQ | Insmed Incorporated | $129.41 | +1.67% | 1.7M | $28.05B |
| MDLN | NASDAQ | Medline Inc. | $32.53 | +0.43% | 4.6M | $27.51B |
| RPRX | NASDAQ | Royalty Pharma plc | $58.61 | -0.24% | 2.6M | $25.98B |
| INCY | NASDAQ | Incyte Corporation | $121.47 | -1.47% | 1.4M | $24.62B |
| BNTX | NASDAQ | BioNTech SE | $96.73 | +0.34% | 1.2M | $24.3B |
| GH | NASDAQ | Guardant Health, Inc. | $157.38 | -1.04% | 695K | $21.12B |
| UTHR | NASDAQ | United Therapeutics Corporation | $497.11 | -1.34% | 359K | $21.1B |
| GMAB | NASDAQ | Genmab A/S | $32.47 | +0.74% | 1.4M | $19.93B |
| VTRS | NASDAQ | Viatris Inc. | $16.51 | +0.79% | 12.2M | $19.23B |
| MEDP | NASDAQ | Medpace Holdings, Inc. | $587.52 | +0.75% | 159K | $16.4B |
| ASND | NASDAQ | Ascendis Pharma A/S | $263.52 | +0.87% | 444K | $16.37B |
| NBIX | NASDAQ | Neurocrine Biosciences, Inc. | $156.22 | -0.22% | 866K | $15.71B |
| JAZZ | NASDAQ | Jazz Pharmaceuticals plc | $245.80 | +2.21% | 423K | $15.44B |
| BBIO | NASDAQ | BridgeBio Pharma, Inc. | $72.44 | -0.08% | 1.8M | $14.19B |
| EXEL | NASDAQ | Exelixis, Inc. | $56.12 | -2.28% | 2.9M | $14.11B |
| SMMT | NASDAQ | Summit Therapeutics Inc. | $17.55 | +3.24% | 4.3M | $14B |
| ICLR | NASDAQ | ICON Public Limited Company | $169.31 | +2.18% | 1.7M | $12.96B |
| HALO | NASDAQ | Halozyme Therapeutics, Inc. | $107.20 | +0.19% | 861K | $12.72B |
| BMRN | NASDAQ | BioMarin Pharmaceutical Inc. | $65.68 | +0.26% | 1.6M | $12.69B |
| MDGL | NASDAQ | Madrigal Pharmaceuticals, Inc. | $534.49 | +0.26% | 188K | $12.35B |
| CORT | NASDAQ | Corcept Therapeutics Incorporated | $112.79 | -1.85% | 1.3M | $12.19B |
| ARWR | NASDAQ | Arrowhead Pharmaceuticals, Inc. | $82.85 | +0.11% | 1.3M | $11.67B |
| BTSG | NASDAQ | BrightSpring Health Services, Inc. Common Stock | $58.73 | +1.47% | 2.5M | $11.53B |
| BTSGU | NASDAQ | BrightSpring Health Services, Inc. Tangible Equity Unit | $194.08 | +0.45% | 2K | $11.4B |
| AXSM | NASDAQ | Axsome Therapeutics, Inc. | $220.75 | +4.56% | 1.2M | $11.36B |
| TECH | NASDAQ | Bio-Techne Corporation | $72.12 | +0.06% | 2.7M | $11.29B |
| ALGN | NASDAQ | Align Technology, Inc. | $150.82 | +0.07% | 620K | $10.8B |
| COO | NASDAQ | The Cooper Companies, Inc. | $53.91 | -0.48% | 6.4M | $10.51B |
| TEM | NASDAQ | Tempus AI, Inc. | $59.01 | +0.46% | 3.7M | $10.34B |
| KRYS | NASDAQ | Krystal Biotech, Inc. | $347.00 | +0.42% | 206K | $10.23B |
| ENSG | NASDAQ | The Ensign Group, Inc. | $173.98 | +0.69% | 314K | $10.14B |
50 Healthcare Companies
Review companies currently returned for the Healthcare screen, with price, performance, volume and market-cap context.
How This Sector Screen Works
Results are loaded from current company data and can be narrowed by exchange or company search without changing the canonical sector page.
About the Healthcare Sector
The Healthcare classification groups companies with related business activities so investors can compare peers within a common market segment.
Related Sector Screens
Return to the screener directory to compare this sector with daily movers and the other industry groups covered by Cashu Finance.